Drupal.behaviors.print = function(context) {window.print();window.close();}>
GE Healthcare Obtains License for c-Met Peptides from Dyax
April 02, 2012
GE Healthcare Obtains License for c-Met Peptides from Dyax
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Insight Genetics Licenses ALK Gene Mutations from St. Jude for Dx Development
December 14, 2010 / GenomeWeb Daily News
Oxford Cancer Biomarkers Developing CDx Biomarkers for AstraZeneca
April 16, 2013 / GenomeWeb Daily News
Foundation Medicine to Develop Dx for Agios Cancer Therapeutics
April 4, 2013 / GenomeWeb Daily News
Leica, Synthon Biopharmaceuticals Partner on CDx Development
March 12, 2013 / GenomeWeb Daily News
AnalizaDx, GHMI Partner to Bring Cancer Dx to Africa, the Caribbean
February 27, 2013 / GenomeWeb Daily News